The abilities of golimumab in the therapy of ankylosing spondylitis
The paper summarizes the data of the GO-RAISE trial evaluating the efficacy and tolerability of golimumab (GLM) in patients with ankylosing spondylitis (AS). The trial was launched in 57 clinical centers of North America, Europe, and Asia in 2005. It enrolled 356 patients with high AS activity (BASD...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2014-09-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/565 |